Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Hermansky-Pudlak syndrome pulmonary fibrosis Indication Strategy Report 2026: TGF-beta, Trials and Deals
30 July 2026
2026 Hermansky-Pudlak syndrome pulmonary fibrosis indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need,…
Latest Hotspot
8 min read
Acute interstitial pneumonia Indication Strategy Report 2026: TGF-beta, Trials and Deals
30 July 2026
2026 Acute interstitial pneumonia indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Spontaneous coronary artery dissection Indication Strategy Report 2026: TGF-beta, Trials and Deals
30 July 2026
2026 Spontaneous coronary artery dissection indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Fibromuscular dysplasia Indication Strategy Report 2026: TGF-beta, Trials and Deals
30 July 2026
2026 Fibromuscular dysplasia indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Endomyocardial fibrosis Indication Strategy Report 2026: TGF-beta, Trials and Deals
30 July 2026
2026 Endomyocardial fibrosis indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Left ventricular noncompaction cardiomyopathy Indication Strategy Report 2026: MYH7, Trials and Deals
30 July 2026
2026 Left ventricular noncompaction cardiomyopathy indication strategy covering epidemiology, MYH7 biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Desmoplakin cardiomyopathy Indication Strategy Report 2026: DSP, Trials and Deals
30 July 2026
2026 Desmoplakin cardiomyopathy indication strategy covering epidemiology, DSP biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Giant cell myocarditis Indication Strategy Report 2026: IL-6, Trials and Deals
30 July 2026
2026 Giant cell myocarditis indication strategy covering epidemiology, IL-6 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
LMNA cardiomyopathy Indication Strategy Report 2026: LMNA, Trials and Deals
30 July 2026
2026 LMNA cardiomyopathy indication strategy covering epidemiology, LMNA biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Transthyretin cardiac amyloidosis wild-type Indication Strategy Report 2026: TTR, Trials and Deals
30 July 2026
2026 Transthyretin cardiac amyloidosis wild-type indication strategy covering epidemiology, TTR biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Brugada syndrome type 1 Indication Strategy Report 2026: SCN5A, Trials and Deals
30 July 2026
2026 Brugada syndrome type 1 indication strategy covering epidemiology, SCN5A biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Progressive cardiac conduction disease Indication Strategy Report 2026: SCN5A, Trials and Deals
30 July 2026
2026 Progressive cardiac conduction disease indication strategy covering epidemiology, SCN5A biology, active trials, transactions, unmet need, competition and…